| [1] |
Sobel JD. Vulvovaginal candidosis[J]. Lancet, 2007, 369(9577):1961-1971.
|
| [2] |
Sawant B, Khan T. Recent advances in delivery of antifungal agents for therapeutic management of candidiasis[J].Biomed Pharmacother, 2017, 96:1478-1490.
|
| [3] |
王焱. 不同治疗方法对妊娠期白色念珠菌性阴道炎的治疗效果[J]. 中外女性健康研究, 2017, (5):90,94.
|
| [4] |
杨心茹, 罗伟, 邢丽枝,等. 妊娠期念珠菌性阴道炎与不良妊娠结局关系的研究进展[J].中国真菌学杂志, 2019, 14(5):313-315.
|
| [5] |
Ameen F, Moslem M, Al Tami M, et al. Identification ofCandida species in vaginal flora using conventional and molecular methods[J]. J Mycol Med, 2017, 27(3):364-368.
|
| [6] |
Gow NAR, Yadav B. Microbe profile:Candida albicans:a shape-changing, opportunistic pathogenic fungus of humans[J]. Microbiology, 2017, 163(8):1145-1147.
|
| [7] |
Noble SM, Gianetti BA, Witchley JN.Candida albicans cell-type switching and functional plasticity in the mammalian host[J]. Nat Rev Microbiol, 2017, 15(2):96-108.
|
| [8] |
Brown AJP, Brown GD, Netea MG, et al. Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels[J]. Trends Microbiol, 2014, 22(11):614-622.
|
| [9] |
刘朝晖,廖秦平.外阴阴道假丝酵母菌病(VVC)诊治规范修订稿[J].中国实用妇科与产科杂志,2012,28(6):401-402.
|
| [10] |
Sadeghi G, Ebrahimi-Rad M, Mousavi SF, et al. Emergence of non-Candida albicans species:epidemiology, phylogeny and fluconazole susceptibility profile[J]. J Mycol Med, 2018, 28(1):51-58.
|
| [11] |
邓丽娜. 克霉唑联合氟康唑治疗复发性念珠菌性阴道炎的疗效观察[J]. 中国处方药, 2019, 17(10):99.
|
| [12] |
王仙. 氟康唑与克霉唑阴道栓联用对念珠菌阴道炎患者的临床疗效探讨[J]. 医学食疗与健康, 2019,(12):64-65.
|
| [13] |
蔡丽华, 蔡文莲. 克霉唑联合左旋咪唑治疗外阴阴道假丝酵母菌病的效果[J]. 中国当代医药, 2019, 26(10):144-146.
|
| [14] |
黎秋燕. 伊曲康唑联合硝酸咪康唑栓治疗VVC的疗效观察及易感因素分析[J]. 首都食品与医药, 2016, 23(12):48-49.
|
| [15] |
冯燕翀, 牛战琴. 乳酸杆菌活菌制剂联合克霉唑治疗外阴阴道假丝酵母菌病的Meta分析[J]. 中国医药科学, 2014, 4(2):43-46.
|
| [16] |
郑素芬. 臭氧联合氟康唑治疗复发性念珠菌性阴道炎疗效观察[J]. 临床合理用药杂志, 2019, 12(22):83-85.
|
| [17] |
邓春荣, 黎宝珍, 黄小艳,等. 维生素C联合克霉唑治疗复发性假丝酵母菌病的效果观察[J].广西医学, 2015, 37(7):969-970.
|
| [18] |
李丽红, 肖泽兰, 莫培晖,等. 黄连煎剂联合克霉唑治疗阴道假丝酵母菌病的疗效观察[J]. 中国地方病防治杂志, 2016, 31(9):1072.
|
| [19] |
李艳红, 尹国武, 杨瑛. 克霉唑联合苦参胶囊治疗重度外阴阴道假丝酵母菌病75例[J]. 医药导报, 2006, 25(9):926-927.
|
| [20] |
Mueller RH, Petersen RD, Hommoss A, et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products[J]. Adv Drug Deliv Rev, 2007, 59(6):522-530.
|
| [21] |
Kenechukwu FC, Attama AA, Ibezim EC, et al. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis[J]. Eur J Pharm Sci, 2018, 111:358-375.
|
| [22] |
Salah S, Awad GEA, Makhlouf AIA. Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel:Formulation development and in vivo therapeutic efficacy in rats[J]. Eur J Pharm Sci, 2018, 114:255-266.
|
| [23] |
De Lima JA,Paines TC,Motta MH,et al. Novel pemulen/pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules:Evaluation of mucoadhesion and vaginal permeation[J]. Mater Sci Eng C-Biomimetic Supramol Syst, 2017, 79:886-893.
|
| [24] |
Taghipour S, Kiasat N, Shafiei S, et al. Luliconazole, a new antifungal against Candida species isolated from different sources[J]. J Mycol Med,2018, 28(2):374-378.
|
| [25] |
Santos CMA, Pires MCV, Leao TL, et al. Anti-inflammatory effect of two Lactobacillus strains during infection with Gardnerella vaginalis and Candida albicans in a HeLa cell culture model[J]. Microbiology, 2018, 164(3):349-358.
|
| [26] |
王业丰, 李晓珍, 宋泽丽, 李婷. 乳酸杆菌活菌制剂联合克霉唑治疗妊娠期阴道念珠菌病的Meta分析[J]. 基层医学论坛, 2019, 23(2):149-152.
|
| [27] |
Molgaard-Nielsen D, Svanstrom H, Melbye M, et al. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth[J]. JAMA-J Am Med Assoc, 2016, 315(1):58-67.
|
| [28] |
Daniel S, Rotem R, Koren G, et al. Vaginal antimycotics and the risk for spontaneous abortions[J]. Am J Obstet Gynecol, 2018, 218(6):601.e1-e7.
|
